Picture of Sapporo Clinical Laboratory logo

9776 — Sapporo Clinical Laboratory News Story

0.000.00%
jp flag iconLast trade - 00:00
Consumer DefensivesBalancedMicro CapSuper Stock

Table: Sapporo Clinical Lab -6-MTH group results

Nov 10 (Reuters)-  
             Sapporo Clinical Laboratory Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 6 months ended      6 months ended       Year to  
                Sep 30, 2015        Sep 30, 2014     Mar 31, 2016  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             8.60                8.30             17.71     
                 (+3.6 pct)          (+1.6 pct)       (+3.2 pct)   
  Operating        501 mln             378 mln          834 mln    
                 (+32.5 pct)         (-15.5 pct)      (-4.0 pct)   
  Recurring        511 mln             394 mln          835 mln    
                 (+29.8 pct)         (-15.0 pct)      (-6.8 pct)   
  Net              320 mln             235 mln          532 mln    
                 (+36.3 pct)         (-13.4 pct)      (-7.1 pct)   
  EPS             92.04 yen           59.06 yen       153.15 yen   
  Ann Div                             12.00 yen        11.00 yen   
  -Q2 div            NIL                 NIL                       
  -Q4 div                             12.00 yen        11.00 yen   
   
  NOTE - Sapporo Clinical Laboratory Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Sapporo Clinical Laboratory

See all news